SVB Wealth’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $27K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $356K | Buy |
|
|||||
|
2023
Q1 | $370K | Sell |
|
|||||
|
2022
Q4 | $487K | Buy |
|
|||||
|
2022
Q3 | $384K | Buy |
|
|||||
|
2022
Q2 | $257K | Buy |
|
|||||
|
2022
Q1 | $287K | Buy |
|
|||||
|
2021
Q4 | $297K | Sell |
|
|||||
|
2021
Q3 | $343K | Buy |
|
|||||
|
2021
Q2 | $299K | Hold |
|
|||||
|
2021
Q1 | $249K | Sell |
|
|||||
|
2020
Q4 | $231K | Hold |
|
|||||
|
2020
Q3 | $259K | Buy |
|
|||||
|
2020
Q2 | $261K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $202K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $208K | Sell |
|
|||||
|
2017
Q4 | $235K | Sell |
|
|||||
|
2017
Q3 | $247K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $210K | Sell |
|
|||||
|
2016
Q2 | $200K | Sell |
|
|||||
|
2016
Q1 | $245K | Hold |
|
|||||
|
2015
Q4 | $368K | Hold |
|
|||||
|
2015
Q3 | $314K | Hold |
|
|||||
|
2015
Q2 | $468K | Hold |
|
|||||
|
2015
Q1 | $408K | Sell |
|
|||||
|
2014
Q4 | $452K | Buy |
|